Related Experiment Videos
Chemotherapy, a double agent in respect of immune functions
Cancer Chemotherapy and Pharmacology
|January 1, 1978
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Phase I trial of cystemustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation scheme.
Drugs under experimental and clinical research·1992
Radical tumor excision and cosmetic balance in the surgical treatment of breast carcinoma: biquadrantectomy.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·1992
Combined differentiation therapy in myelodysplastic syndrome with retinoid acid, 1 alpha,25 dihydroxyvitamin D3, and prednisone.
Cancer detection and prevention·1992
Retrospective study correlating clinical infectious history and peripheral blood T-cell subpopulations in cancer, GvH and HIV+ patients.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·1992
Retinoic acid in mono- or combined differentiation therapy of myelodysplasia and acute promyelocytic leukemia.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·1991
Intensification versus combination: revisiting the past and envisioning the future of LDHA inhibitors.
Cancer chemotherapy and pharmacology·2026
Circulatory compromise as a potential mechanism of fatal hepatic failure during long-term selpercatinib therapy: pharmacokinetic and clinical insights.
Cancer chemotherapy and pharmacology·2026
CDCP1-targeted antibody-drug conjugates and immunocytokines for cancer therapy.
Cancer chemotherapy and pharmacology·2026
Pharmacokinetic and pharmacodynamic sub-study of trans-arterial vs. intravenous gemcitabine in the TIGeR-PaC phase 3 clinical trial.
Cancer chemotherapy and pharmacology·2026
A phase 1, open-label study evaluating the pharmacokinetics, safety, and tolerability of vepdegestrant in Chinese patients with ER+/HER2- advanced breast cancer.
Cancer chemotherapy and pharmacology·2026
Quantitative characterization of platelet count and alanine aminotransferase dynamics to inform personalized dosing in the first-in-human LP-184 trial.
Cancer chemotherapy and pharmacology·2026